Sign inJoin waitlistJoin the waitlist

Herbert A. Eradat

Internal Medicine · The Regents of the University of California

Credentials: · · · ·

History

Research

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2014 · 1,384 citations
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology · 2018 · 552 citations
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia
Journal of Clinical Oncology · 2019 · 201 citations

Thomas Kipps
9 papers
William Wierda
7 papers · 2 as a fellow
Richard Furman
6 papers
Shuo Ma
6 papers
Jennifer Brown
5 papers
Steven Coutre
5 papers
BC
Bruce Cheson
4 papers
JP
John Pagel
4 papers
LP
Lauren Pinter-Brown
4 papers
LH
Leonard Heffner
4 papers
MD
Madeleine Duvic
4 papers
Stephen Schuster
4 papers

Clinical trials

To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Site PI · Recruiting · Phase 3
Acrotech Biopharma Inc.
2023–2030